| 1.6 |
4.7 |
GO:0001907 |
cytolysis by symbiont of host cells(GO:0001897) killing by symbiont of host cells(GO:0001907) hemolysis by symbiont of host erythrocytes(GO:0019836) disruption by symbiont of host cell(GO:0044004) hemolysis in other organism(GO:0044179) positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) cytolysis in other organism(GO:0051715) cytolysis in other organism involved in symbiotic interaction(GO:0051801) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 1.1 |
4.3 |
GO:0071379 |
cellular response to prostaglandin stimulus(GO:0071379) |
| 1.0 |
10.4 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.9 |
3.7 |
GO:0001969 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.7 |
5.2 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.6 |
3.8 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.6 |
1.8 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.6 |
2.3 |
GO:0010727 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.3 |
2.5 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.3 |
5.9 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.2 |
1.6 |
GO:0071731 |
response to nitric oxide(GO:0071731) |
| 0.2 |
1.1 |
GO:0042905 |
retinal metabolic process(GO:0042574) 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.2 |
4.2 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.2 |
0.7 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.2 |
1.5 |
GO:0043545 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.2 |
1.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
3.4 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.1 |
8.6 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.4 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
1.4 |
GO:0030147 |
obsolete natriuresis(GO:0030147) |
| 0.1 |
0.5 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
2.2 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
0.4 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.7 |
GO:0034331 |
cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.3 |
GO:0042759 |
fatty acid elongation, saturated fatty acid(GO:0019367) long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 |
3.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.1 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
| 0.1 |
0.2 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.1 |
0.7 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.1 |
0.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) actin filament reorganization(GO:0090527) |
| 0.1 |
0.9 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
1.4 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of wound healing(GO:0061045) negative regulation of hemostasis(GO:1900047) |
| 0.0 |
0.7 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.2 |
GO:0045767 |
obsolete regulation of anti-apoptosis(GO:0045767) |
| 0.0 |
0.2 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
1.0 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
1.5 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.0 |
0.2 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.7 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.3 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.4 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.0 |
GO:0071474 |
cellular water homeostasis(GO:0009992) cellular hyperosmotic response(GO:0071474) |
| 0.0 |
0.2 |
GO:0043174 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
